Protagonist Therapeutics Inc (PTGX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 60M | 254.95M | 4.17M |
| Operating Income | -32.3M | -36.52M | -36.02M | -42.35M | -38.33M | 23.05M | 206.31M | -38.79M |
| Pre Tax Income | -31.23M | -34.19M | -33.73M | -38.46M | -34.11M | 27.34M | 210.67M | -31.29M |
| Net Income | -31.23M | -34.19M | -33.73M | -38.46M | -34.11M | 27.34M | 207.34M | -30.62M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | -32.39M | -36.45M | -36.22M | -42.37M | -38.36M | 23.09M | 206.29M | -38.7M |
| EBITDA | -32.03M | -36.26M | -35.77M | -42.12M | -38.08M | 23.3M | 206.55M | -38.55M |
| Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 20.06M | 30.93M | 231k | 28.63M | 27.36M | 26.58M | 60M |
| Operating Income | -32.67M | -37.9M | -42.27M | -80.52M | -64.52M | -125.85M | -131.37M | -93.65M |
| Pre Tax Income | -37.18M | -36.96M | -39.72M | -77.88M | -64.85M | -125.55M | -127.39M | -78.96M |
| Net Income | -37.74M | -36.96M | -38.92M | -77.19M | -66.15M | -125.55M | -127.39M | -78.96M |
| Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Basic Earnings Per Share (EPS) | -2.257 | -1.753 | -1.679 | -2.836 | -1.512 | -2.625 | -2.582 | -1.369 |
| EBIT | -32.7M | -37.9M | -42.27M | -80.52M | -65.15M | -125.99M | -131.45M | -93.85M |
| EBITDA | -32.35M | -37.49M | -41.74M | -79.82M | -63.73M | -125.03M | -130.34M | -92.68M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
